NCT02575846

Brief Summary

The purpose of this study is to determine which type of food results in a shorter hospital stay and better overall outcome for babies born with gastroschisis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2015

Completed
9 days until next milestone

First Posted

Study publicly available on registry

October 15, 2015

Completed
1 month until next milestone

Study Start

First participant enrolled

November 26, 2015

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 11, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 11, 2016

Completed
Last Updated

April 12, 2024

Status Verified

June 1, 2017

Enrollment Period

12 months

First QC Date

October 6, 2015

Last Update Submit

April 11, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Length of Hospital Stay

    One month

Secondary Outcomes (2)

  • Time to Full Enteral Feeds

    Three weeks

  • Time on Total Parenteral Nutrition

    Three weeks

Study Arms (2)

Human Milk

ACTIVE COMPARATOR

Neonates fed human milk

Dietary Supplement: Enteral Intake - Human Milk

Formula

PLACEBO COMPARATOR

Neonates fed formula

Dietary Supplement: Enteral Intake - Formula

Interventions

Enteral Intake - Human MilkDIETARY_SUPPLEMENT

Comparing formula and human milk

Human Milk
Enteral Intake - FormulaDIETARY_SUPPLEMENT

Comparing formula and human milk

Formula

Eligibility Criteria

Age2 Hours - 48 Hours
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • \) neonates born with gastroschisis
  • \) neonatologist, surgeon, and parent (or care provider) willing to have the neonate participate in the study

You may not qualify if:

  • \) associated anomaly or medical concern that impacts hospital length of stay (i.e. intestinal atresia, very low birth weight(\<1500 grams))
  • \) known major chromosomal abnormality

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Medical Center

Durham, North Carolina, 27710, United States

Location

Related Publications (4)

  • Kohler JA Sr, Perkins AM, Bass WT. Human milk versus formula after gastroschisis repair: effects on time to full feeds and time to discharge. J Perinatol. 2013 Aug;33(8):627-30. doi: 10.1038/jp.2013.27. Epub 2013 Mar 21.

    PMID: 23519369BACKGROUND
  • Sydorak RM, Nijagal A, Sbragia L, Hirose S, Tsao K, Phibbs RH, Schmitt SK, Lee H, Farmer DL, Harrison MR, Albanese CT. Gastroschisis: small hole, big cost. J Pediatr Surg. 2002 Dec;37(12):1669-72. doi: 10.1053/jpsu.2002.36689.

    PMID: 12483626BACKGROUND
  • Mastromarino P, Capobianco D, Campagna G, Laforgia N, Drimaco P, Dileone A, Baldassarre ME. Correlation between lactoferrin and beneficial microbiota in breast milk and infant's feces. Biometals. 2014 Oct;27(5):1077-86. doi: 10.1007/s10534-014-9762-3. Epub 2014 Jun 27.

    PMID: 24970346BACKGROUND
  • Gomez-Llorente C, Plaza-Diaz J, Aguilera M, Munoz-Quezada S, Bermudez-Brito M, Peso-Echarri P, Martinez-Silla R, Vasallo-Morillas MI, Campana-Martin L, Vives-Pinera I, Ballesta-Martinez MJ, Gil A. Three main factors define changes in fecal microbiota associated with feeding modality in infants. J Pediatr Gastroenterol Nutr. 2013 Oct;57(4):461-6. doi: 10.1097/MPG.0b013e31829d519a.

    PMID: 23752082BACKGROUND

MeSH Terms

Conditions

Gastroschisis

Condition Hierarchy (Ancestors)

Musculoskeletal AbnormalitiesMusculoskeletal DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Obinna O Adibe, MD, MHS

    Duke University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 6, 2015

First Posted

October 15, 2015

Study Start

November 26, 2015

Primary Completion

November 11, 2016

Study Completion

November 11, 2016

Last Updated

April 12, 2024

Record last verified: 2017-06

Locations